About: Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 15 June 2005

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2005 (uk) im Juni 2005 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 15 June 2005 (en) artículu científicu espublizáu en xunu de 2005 (ast)
publication date	wds:Q81858301-F98F27AA-1C88-454A-95D8-F5096086671C
publication date	2005-06-15 00:00:00Z (xsd:dateTime)
exact match	wds:Q81858301-B9ED61A1-B55B-4E10-97EA-3F886ADE3AA5
exact match	https://scigraph.springernature.com/pub.10.1007/s00702-005-0323-3
cites work	wds:Q81858301-02D296FF-3996-44FC-9862-63091A25488C wds:Q81858301-17C93602-A19B-4210-AB7E-0600089CC82D wds:Q81858301-1DD40FC5-5957-4C44-8CFB-DF9FE5E46903 wds:Q81858301-1EC22341-B9EE-401B-B301-A9C1C294FEC5 wds:Q81858301-32929845-F654-4D08-B1E1-CBF68C970473 wds:Q81858301-3CB68CA4-33C2-4562-9963-E121ECA20457 wds:Q81858301-4BC06D5D-4CE2-4A75-BA12-52D74AFEBD14 wds:Q81858301-6080CF1E-42B9-4129-B0AE-3A25BD3BC0A5 wds:Q81858301-672526A0-24A5-431E-8CD4-903851FF2355 wds:Q81858301-6F193B1C-71F5-472D-8731-A84098354131 wds:Q81858301-6F86E19C-E744-45CB-8E62-EB52E3B774F3 wds:Q81858301-723BED7E-CA27-442C-8379-09C07BA3011F wds:Q81858301-A8E79769-B167-4FDB-9520-926D91C6FBF0 wds:Q81858301-A8F4A792-C911-4F43-AC92-4ECB9D8FC214 wds:Q81858301-AA34675B-9EA1-4F0A-B290-D2908764C233 wds:Q81858301-AEF59D08-1BDE-412A-96E4-0C93B0A79475 wds:Q81858301-AF2487BE-514C-4ED2-BCA9-C9C08431CF27 wds:Q81858301-B5E80C22-3CE7-42A5-B065-16A1A5211177 wds:Q81858301-BF56BF65-8CEA-4C00-9F58-CEB505DD3527 wds:Q81858301-C28059BD-9FCD-424F-87A2-208B116A69C0 wds:Q81858301-D5400972-3C45-4536-AC39-A55D1F68412C wds:Q81858301-EEEFFE87-95DA-493B-9858-10FA07D5512A wds:Q81858301-F138D054-AD6A-4781-811D-1DBA6EE929C5 wds:Q81858301-F2C3CA31-8E6F-4F3A-B47D-DECBB824488E wds:Q81858301-F8C74301-CE67-4469-96CA-371D94FF5968 wds:Q81858301-FB28E452-540A-46FD-93F3-E9028F4A6F59 wds:Q81858301-FE3E15EA-8EB3-41D8-8357-61F6F27F95E0
cites work	Botulinum toxin type A therapy for blepharospasm Blepharospasm: a review of 264 patients Pretarsal application of botulinum toxin for treatment of blepharospasm Botulinum A toxin injection as a treatment for blepharospasm Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm Pathophysiology of dystonia: a neuronal model Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study Blepharospasm: demographic and clinical survey of 250 patients Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis. Prevalence of focal dystonias in the western area of Tottori Prefecture in Japan. Management of spasticity associated pain with botulinum toxin A. Sex-related influences on the frequency and age of onset of primary dystonia. Epidemiologic Study of Dystonia in Europe (ESDE) Collaborative Group Blepharospasm: past, present, and future Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences Development of resistance to botulinum toxin type A in patients with torticollis Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX) in healthy volunteers Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study. Prevalence of primary blepharospasm in a community of Puglia region, Southern Italy. Clinical presentation and management of antibody-induced failure of botulinum toxin therapy Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force Abnormal eye movements in blepharospasm and involuntary levator palpebrae inhibition. Clinical and pathophysiological considerations. Treatment choices of 119 patients with hemifacial spasm over 11 years Botulinum toxin therapy, immunologic resistance, and problems with available materials Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm Treatment of blepharospasm with high dose brow injection of botulinum toxin
author name string	wds:Q81858301-3B70C171-C31F-454E-90E6-9F13E98798CC wds:Q81858301-461FB570-B5F3-4C8E-B47D-8F008D611AF6 wds:Q81858301-8C0CCBA5-CDED-4047-9606-26E1BBEEAE17 wds:Q81858301-9C2729BD-14D1-4D43-A44A-D2B5A9766AD9 wds:Q81858301-CFAA9D85-9348-403D-AD77-4FE634D0CD83 wds:Q81858301-F6B01AE9-36B8-45A0-9CC2-B9297D341969
author name string	W H Jost G Comes P Roggenkämper S Grafe K Bihari NT 201 Blepharospasm Study Team
rdfs:label	Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm (en) Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm (nl)
skos:prefLabel	Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm (en) Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm (nl)
name	Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm (en) Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm (nl)
title	wds:Q81858301-F0D6291E-799F-47B2-AB1B-629E06E8D2B5
title	Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm (en)
page(s)	wds:Q81858301-71CCFBD9-57A7-485E-98C2-A749EF9DB53E
page(s)	303-312
instance of	wds:Q81858301-234AFDA0-EF64-43B1-A3D7-2BF9A950969A
instance of	scholarly article
main subject	wds:Q81858301-89BEA1F2-E2C5-4DDB-BB45-35DDBF27C21D wds:Q81858301-DF185FF6-3355-4A8D-8EC1-477A0A173753
main subject	botulinum toxin type A blepharospasm
PubMed ID	wds:Q81858301-CF8E8CE1-4502-49B7-9164-300D42896C5F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15959841
PubMed ID	15959841
published in	wds:Q81858301-FAA9A2F0-BCC8-42C7-8917-72A1333BBD4C
published in	Journal of Neural Transmission
issue	wds:Q81858301-32431DE3-7D82-40A1-89D7-EC472600E7E4
volume	wds:Q81858301-2F2970ED-87B9-4FB1-A953-3954CCF8F43E
issue	3

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software